Advertisements



Medtronic begins initial European launch of MiniMed Duo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJun 3rd, 2014

Horizon Pharma"s (HZNP) CEO Tim Walbert on Q1 2014 Results - Earnings Call Transcript

Horizon Pharma, Inc. (HZNP) Q1 2014 Results Earnings Conference Call May 09, 2014 08:00 AM ET Executives Bob De Vaere - EVP and Chief Financial Officer Tim Walbert - Chairman, President and CEO Tod Smith - EVP and Chief Commercial Officer Analysts.....»»

Category: topSource: seekingalphaMay 9th, 2014

Horizon Pharma Has Significant Growth Potential

By ONeil Trader:Horizon Pharma (HZNP) had a truly transformational year in 2013, and is set to deliver strong revenue growth and achieve non-GAAP profitability in 2014. The company successfully marketed Duexis and Rayos, acquired the rights for Vimovo fro.....»»

Category: topSource: seekingalphaMar 20th, 2014

Buy Horizon Pharma On Upcoming Revenue Growth

By Equity Flux: Introduction Horizon Pharma develops and commercializes products that target arthritis, pain and inflammatory diseases. The company is currently marketing Duexis, Rayos/Lodotra and the newly acquired Vimovo to orthopedic surgeons and rhe.....»»

Category: topSource: seekingalphaMar 5th, 2014

Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs

Horizon Pharma, Inc., (NASDAQ: HZNP), a commercial stage, specialty pharmaceutical company that markets two gastroprotective nonsteroidal anti-inflammatory drugs (NSAIDs), VIMOVO(R) (naproxen/esomeprazole magnesium) and DUEXIS(R) (ibuprofen and famotidine.....»»

Category: blogSource: benzingaFeb 11th, 2014

Horizon Pharma says Par to withdraw ANDA for generic Rayos

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallNov 22nd, 2013

Volcano Launches Crux Vena Cava Filter - Analyst Blog

Volcano expands Product portfolio with the commercial launch of Crux Vena Cava Filter Volcano Corporation (VOLC) announced the commercial release as well as the initial implantations of the novel device – Crux Vena Cava Filter (VCF). Th.....»»

Category: topSource: zacksNov 14th, 2013

Horizon Pharma Continues Cash Burn And Dilution

By Chimera Research Group: By Patrick Crutcher We last wrote on Horizon Pharma (HZNP) following their FDA approval of RAYOS, but seems not much has changed. However, the stock has risen roughly 60% year to date with no apparent change in fundamentals. W.....»»

Category: topSource: seekingalphaNov 8th, 2013

Horizon Pharma presents newe clinical data on Rayos DR tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallOct 29th, 2013

Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting

Horizon Pharma, Inc (NASDAQ: HZNP) today announced that two published abstracts of its approved treatment RAYOS(R) (prednisone) delayed-release tablets will be presented during the American College of Rheumatology (ACR)/Association of Rheumatology Health .....»»

Category: blogSource: benzingaOct 21st, 2013

Horizon Pharma downgraded to Neutral from Overweight at Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewall13 hr. 11 min. ago

Horizon Pharma Plummets After Arthritis Drugs Placed On Exclusion List

Shares of Horizon Pharma Inc. (HZNP) are declining today after it indicated that its two best-selling arthritis drugs, Duexis and Vimovo, may be in for a tough time come January 1. Shares of Horizon Pharma Inc. (HZNP) are declining today after it indica.....»»

Category: topSource: bidnessetcJul 28th, 2014

Horizon Pharma shares offer "significant value," says Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJul 28th, 2014

Horizon Pharma Shares Fall as Drugs Added to Exclusion List

Horizon Pharma shares fell as company said CVS Caremark Corp. and Express Scripts Holding Co. will place Horizon's two biggest selling drugs on their exclusion lists at the start of next year......»»

Category: topSource: wsjJul 28th, 2014

Update: Horizon Pharma"s Duexis And Vimovo To Be Taken Off Formularies By Express Scripts And CVS Caremark In 2015

By ONeil Trader:Horizon Pharma (NASDAQ:HZNP) is down significantly in pre-market today after the company announced that Express Scripts (NASDAQ:ESRX) and CVS Caremark (NYSE:CVS) have verbally informed the company that they expect to announce that Duexis a.....»»

Category: topSource: seekingalphaJul 28th, 2014

Horizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJul 28th, 2014

Commit To Purchase Horizon Pharma At $8, Earn 13.1% Using Options

Stock Options Channel.....»»

Category: topSource: redinewsJul 25th, 2014

Commit To Purchase Horizon Pharma At $8, Earn 13.1% Using Options

Investors eyeing a purchase of Horizon Pharma Inc (NASD: HZNP) shares, but tentative about paying the going market price of $13.93/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put c.....»»

Category: marketsSource: forbesJul 25th, 2014

Boston Scientific Rises on Launch of POLARIS Imaging System - Analyst Blog

Share price of medical device major Boston Scientific Corporation (BSX) rose 2.4% yesterday, following the full commercial launch of its new POLARIS system Share price of medical device major Boston Scientific Corporation (BSX) rose 2.4% yest.....»»

Category: topSource: zacksJul 23rd, 2014

Apple Plans Biggest iPhone Launch Ever With All Eyes on Fall

Investors and consumers alike look to an eventful fall that will see Apple undertake its biggest initial iPhone production run yet. Source: Apple.com Apple (NASDAQ:AAPL) seems to be gearing up for an eventful fall with what will be the company’s.....»»

Category: technologySource: wallstcheatsheetJul 23rd, 2014